BRIEF-Mdxhealth Reports Q1-2026 Results

MDxHealth

MDxHealth

MDXH

0.00

May 13 (Reuters) - MDxHealth SA MDXH.O:

  • MDXHEALTH REPORTS Q1-2026 RESULTS

  • TO DISCONTINUE RESOLVE UTI OFFERING AND PLANO, TEXAS LAB OPERATIONS

  • SETS 2026 CORE CANCER BUSINESS REVENUE GUIDANCE AT $110-$115 MILLION EXCLUDING RESOLVE

  • Q1 2026 REVENUE $27.4 MILLION, UP 13% YEAR-OVER-YEAR

  • MDXHEALTH: CONTESTING $10.4 MILLION MEDICARE CONTRACTOR'S RECOUPMENT DECISION FROM NOVITAS ON RETROSPECTIVE REVIEW OF SOME HISTORICAL RESOLVE MDX CLAIMS

  • : QTRLY LOSS PER SHARE 17 CENTS

  • Q1 EARNINGS PER SHARE VIEW $-0.15, REVENUE VIEW $30.6 MILLION -- LSEG IBES DATA

Source text: ID:nGNX6QXlVS

Further company coverage: MDXH.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.